REFERENCES
- Avants S K, Margolin A, Warburton L A, Hawkins K A, Shi J. Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. Am J Addict 2001; 10: 69–78, [PUBMED], [INFOTRIEVE], [CSA]
- Basso M R, Bornstein R A. Effects of past noninjection drug abuse upon executive function and working memory in HIV infection. J Clin Exp Neuropsychol 2003; 25: 893–903, [PUBMED], [INFOTRIEVE], [CSA]
- Cook J A, Cohen M H, Burke J, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women Higher scores represent better quality of life. J Acquir Immune Defic Syndr 2002; 30: 401–409, [PUBMED], [INFOTRIEVE]
- Evans D L, Ten Have T R, Douglas S D, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 2002; 159: 1752–1759, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Farinpour R, Miller E N, Satz P, et al. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol 2003; 25: 654–670, [PUBMED], [INFOTRIEVE], [CSA]
- Hays R D, Cunningham W E, Sherbourne C D, Wilson I B, Wu A W, Cleary P D, et al. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV cost and services utilization study. Am J Med 2000; 108: 714–722, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ickovics J, Rodin J. Women and AIDS in the United States: epidemiology, natural history and mediating mechanisms. Health Psychol 1992; 11: 1–16, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ickovics J R, Hamburger M E, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA 2001; 285: 1466–1474, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jacobson D L, Wu A W, Feinberg J, et al. Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. J Clin Epidem 2003; 56: 874–879, [CSA], [CROSSREF]
- Lyketsos C G, Hoover D R, Guccione M, et al. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry 1996; 153: 1430–1437, [PUBMED], [INFOTRIEVE]
- Lyvers M, Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav 2003; 28: 605–611, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Margolin A, Avants S K, Warburton L A, Hawkins K A. Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users. AIDS Patient Care STDs 2002; 16: 255–267, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Matochik J A, London E D, Eldreth D A, Cadet J L, Bolla K I. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. NeuroImage 2003; 19: 1095–1102, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McClure J B, Catz S L, Prejean J, Brantley P J, Jones G N. Factors associated with depression in a heterogeneous HIV-infected sample. J Psychosom Res 1996; 40: 407–415, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McDonnell K A, Gielen A C, Wu A W, O'Campo P, Faden R. Measuring health related quality of life among women living with HIV. Quality Life Res 2000; 9: 931–940, [CSA], [CROSSREF]
- Morrison M F, Petitto J M, Ten Have T, et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry 2002; 159: 789–796, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rabkin J G, Johnson J, Lin S H, et al. Psychopathology in male and female HIV-positive and negative injecting drug users: longitudinal course over 3 years. AIDS 1997; 11: 507–515, [PUBMED], [INFOTRIEVE]
- Revicki D A, Sorenson S, Wu A W. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998; 36: 126–137, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Richardson J, Barkan S, Cohen M, et al. Experience and covariates of depressive symptoms among a cohort of HIV infected women. Soc Work Health Care 2001; 32: 93–111, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rippeth J D, Heaton R K, Carey C L, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 2004; 10: 1–14, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Selnes O A, Galai N, Bacellar H, et al. Cognitive performance after progression to AIDS: A longitudinal study from the Multicenter AIDS Cohort Study. Neurology 1995; 46: 267–275, [CSA]
- Selnes O A. Neurocognitive aspects of medication adherence in HIV infection. JAIDS 2002; 31: S132–S135, [PUBMED], [INFOTRIEVE]
- Sherbourne C D, Hays R D, Fleishman J A, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry 2000; 157: 248–254, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sherwin B B. Estrogen and cognitive functioning in women. Endocr Rev 2003a; 24: 133–151, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sherwin B B. Steroid hormones and cognitive functioning in aging men: a mini-review. J Mol Neurosci 2003b; 20: 385–393, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Starace F, Ammassari A, Trotta M P, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. JAIDS 2002; 31: S136–S139, [PUBMED], [INFOTRIEVE]
- Turner B J, Laine C, Cosler L, Hauck W W. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med 2003; 18: 248–257, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vazquez-Justo E, Alvarez M R, Otero M JF. Influence of depressed mood on neuropsychologic performance in HIV-seropositive drug users. Psychol Clin Neurosci 2003; 57: 251–258, [CSA], [CROSSREF]
- Exploring the biological contributions to human health. Does gender matter?, T M Wizemann, M L Pardue. The National Academic Press., Washington, DC 2001
- Wu A W, Rubin H R, Mathews W C, et al. A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infections. Med Care 1991; 29: 786–798, [PUBMED], [INFOTRIEVE]
- Wu A W, Revicki D A, Malitz F E. Evidence for the reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality Life Res 1997; 6: 481–493, [CSA], [CROSSREF]